ImmunityBio, Inc. IBRX
At closeNov 12, 2026, 7:59 PM EST
After hours · Nov 12, 7:59 PM ET
- YTD
- +206.57%
- 1 year
- +194.66%
Discussion (3506)
Sign in to join the discussion
Daredevil your IQ must be about 85
Daredevil go fuck yourself your posts are lies. ImmunityBio has revenue
I am sure King Charles is getting Anktiva
It's way more fun when it goes up.
Sales will explode and earnings will happen and more approvals will happen. When those things happen the stock explodes higher.
Need to relax and remember the science and the huge potential. Shorts are not an issue over time so ignore the short term focus on the 2-5 years potential
Maybe FDA is dragging feet so Medicare and Medicaid and other insurance carriers won't be required to pay
Lance
I agree.... Anktiva will have more uses then Keytruda and it will happen fast and it works when Keytruda is failing.
The clinical data say Anktiva works for papillary bladder cancer and prevents bladder removal.
It will be approved and should have been before. FDA was protecting 80% of the bladder cancer market for hello Keytruda and Merck.
Paul Silberberg
love your posts!!!!
The FDA has no credibility. They have approved so many drugs with horrific side effects. They gave mRNA jabs for Covid emergency use authorization and as many many side effects surfaced they never rescinded it and still have not.
To Nick
Great post well stated ?
